Greg Walden: “So FDA needs to respond to the overall challenges of foreign drug inspections with more vigor.”

The FCC Process Reform Act is bipartisan legislation that passed the House on March 11 of this year and would bring needed reforms to the commission's processes.

We need to make sure it is getting to the right places.

I don't believe I have any other speakers on my side of the aisle on this measure. I urge its passage, and I yield back the balance of my time.

I want to make sure that it is a responsible way for all parties, which is why a number of us are very concerned about the administration's recent support of the waiver to release and transfer the IP for the vaccine.